# Novomedix LLC

Canonical: https://abierto.us/vendors/novomedix-llc-xqymhkgdmu75

- UEI: XQYMHKGDMU75
- CAGE: 4C2X1
- Location: San Diego, CA
- Awards in window: 2 (3 transactions), $2,977,013 obligated, April 12, 2024 to September 30, 2025

## Awarding agencies

- National Institutes of Health: 2 awards, $2,977,013

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,977,013

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- 75N91025C00051 (definitive contract): $2,977,013, NIH NCI. SBIR Phase II - Enhanced Overall Survival in High-Risk Pediatric Solid Tumors Using a Novel Oral Small Molecule. https://www.usaspending.gov/award/CONT_AWD_75N91025C00051_7529_-NONE-_-NONE-/
- 75N91022C00001 (definitive contract): $0, NIH NCI. SBIR Concept Award to Novomedix- Novel Small Molecules for the Treatment of Rhabdomyosarcoma. https://www.usaspending.gov/award/CONT_AWD_75N91022C00001_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/novomedix-llc-xqymhkgdmu75.